HIGHLIGHTS
- who: Yan Zhang from the GLITTERS is a multicenter, randomized, double-blind, placebo-controlled trial over , weeks (Fig1). The ethics approval in all four centers has been received from the Medical Ethics Committee before the recruitment. The principal study center is Zhujiang Hospital of Southern Medical University (2021-KY-183-02), and the other have published the Article: Efficacy and safety of GLucocorticoid injections into InfrapaTellar faT pad in patients with knee ostEoarthRitiS: protocol for the GLITTERS randomized controlled trial, in the Journal: (JOURNAL) of 23/03/2022
- what: The aim is to assess whether . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.